| Year - Ending | Revenue | Operating Income | Net Income |
| Jan-2023 | 861 | 37 | -26 (Loss) |
| Jan-2022 | 756 | 40 | -44 (Loss) |
| Jan-2021 | 733 | 80 | 8 |
| Jan-2020 | 531 | 109 | 39 |
| Jan-2019 | 287 | 77 | 73 |
HealthEquity, Inc.
HQYHealthEquity, Inc. in brief
HealthEquity, Inc. is a listed company in the Healthcare Information Services industry, based in Draper, Utah, USA. It was founded in 2002. Its market value was $8.3 B on 28 October 2026, which makes it the 2,473rd largest listed company in the world and the 776th largest in the USA on this site. In the year to January 2026 it had sales of $1.3 B and a net profit of $215 M, about 16 cents of profit for every dollar of sales. It employs about 2,814 people and Steve Cutler is its chief executive. Its largest product and service lines by sales in 2026 were Custodial (48%) and Interchange (15%). Its shares trade under the symbol HQY (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About HealthEquity, Inc.
HealthEquity, Inc. is an American financial technology and business services company that is designated as a non-bank health savings trustee by the IRS. This designation allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with.
As of July 31, 2022, HealthEquity managed 7.5 million HSA accounts, plus 7 million other consumer-directed benefits ("CDBs") for total accounts of 14.5 million. Total HSA assets as of July 31, 2022 were $20.5 billion, including $13.1 billion of HSA cash and $7.4 billion of HSA investments.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
HealthEquity, Inc. timeline
- 2002
- 🏁Founded
- 2008
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2014
- 🔔· approximateInitial public offering on Nasdaq
- 2018
- •Legal Entity Identifier issuedLEI 529900LRJU1RAFQHM467 registered.
- 2024
- 💰Revenue passed $1 billionFY2024 revenue of $1.2 billion, up from $1000 million in FY2023.
- 2025
- 💰Record revenue of $1.3 billionFY2025, the highest of the 8 years on record.
- 💰Record net income of $215 millionFY2025, the highest profit of the 6 years on record.
Events of HealthEquity, Inc. from Wikidata, SEC EDGAR, the company record, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #873 (Jan 2020) · #929 (Jan 2021) · #1,321 (Jan 2022) · #848 (Dec 2022) · #918 (Jul 2023) · #855 (Jan 2024) · #796 (Aug 2026) · #826 (Oct 2026) · #777 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- 35.3×
- Price / sales (TTM)
- 6.1×
- Price / book
- 4.0×
- Free cash flow yield
- 5.5%
- Net margin (TTM)
- 17.4%
- Operating margin
- 24.6%
- Return on equity
- 11.2%
- Liabilities / assets
- 37.7%
- Net debt
- $638M
- Revenue growth
- +9.5%
- R&D / revenue
- 20.0%
- Revenue per employee
- $467 K
- Profit per employee
- $76 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Jan 2026 | $1.3B | +9.5% | $322M | $215M | 16.4% |
| Jan 2025 | $1.2B | +20.0% | $162M | $97M | 8.1% |
| Jan 2024 | $1000M | +16.0% | $118M | $56M | 5.6% |
| Jan 2023 | $862M | +13.9% | $9M | $-26M | -3.0% |
| Jan 2022 | $757M | +3.1% | $-24M | $-44M | -5.9% |
| Jan 2021 | $734M | +37.9% | $34M | $9M | 1.2% |
| Jan 2020 | $532M | +85.2% | $77M | $40M | 7.5% |
| Jan 2019 | $287M | — | $78M | $74M | 25.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Jan 2026 | $457M | $2M | $455M | $2.46 | — |
| Jan 2025 | $340M | $2M | $338M | $1.09 | — |
| Jan 2024 | $243M | $2M | $241M | $0.64 | — |
| Jan 2023 | $151M | $3M | $147M | $-0.31 | — |
| Jan 2022 | $141M | $9M | $132M | $-0.53 | — |
| Jan 2021 | $182M | $13M | $169M | $0.12 | — |
| Jan 2020 | $105M | $7M | $98M | $0.58 | — |
| Jan 2019 | $113M | $4M | $110M | $1.17 | — |
Quarterly results
Latest quarter to Jul 2026: revenue $351M (+7.6% on a year earlier), net income $66M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jul 2026.
Annual and quarterly reports
HealthEquity, Inc.'s reports from the last 8 years, from the official filing system. Downloads (Excel financial statements, PDF, the report as filed, or everything as a ZIP) are for Premium subscribers — sign in.
Annual · 8
- Jan 31, 202610-KAnnual reportExcelReportZIP
- Jan 31, 202510-KAnnual reportExcelReportZIP
- Jan 31, 202410-KAnnual reportExcelReportZIP
- Jan 31, 202310-KAnnual reportExcelReportZIP
- Jan 31, 202210-KAnnual reportExcelReportZIP
- Jan 31, 202110-KAnnual reportExcelReportZIP
- Jan 31, 202010-KAnnual reportExcelReportZIP
- Jan 31, 201910-KAnnual reportExcelReportZIP
Quarterly · 23
- Jul 31, 202610-QQuarterly reportExcelReportZIP
- Apr 30, 202610-QQuarterly reportExcelReportZIP
- Oct 31, 202510-QQuarterly reportExcelReportZIP
- Jul 31, 202510-QQuarterly reportExcelReportZIP
- Apr 30, 202510-QQuarterly reportExcelReportZIP
- Oct 31, 202410-QQuarterly reportExcelReportZIP
- Jul 31, 202410-QQuarterly reportExcelReportZIP
- Apr 30, 202410-QQuarterly reportExcelReportZIP
- Oct 31, 202310-QQuarterly reportExcelReportZIP
- Jul 31, 202310-QQuarterly reportExcelReportZIP
- Apr 30, 202310-QQuarterly reportExcelReportZIP
- Oct 31, 202210-QQuarterly reportExcelReportZIP
- Jul 31, 202210-QQuarterly reportExcelReportZIP
- Apr 30, 202210-QQuarterly reportExcelReportZIP
- Oct 31, 202110-QQuarterly reportExcelReportZIP
- Jul 31, 202110-QQuarterly reportExcelReportZIP
- Apr 30, 202110-QQuarterly reportExcelReportZIP
- Oct 31, 202010-QQuarterly reportExcelReportZIP
- Jul 31, 202010-QQuarterly reportExcelReportZIP
- Apr 30, 202010-QQuarterly reportExcelReportZIP
- Oct 31, 201910-QQuarterly reportExcelReportZIP
- Jul 31, 201910-QQuarterly reportExcelReportZIP
- Apr 30, 201910-QQuarterly reportExcelReportZIP
SEC filings
- Oct 9, 20268-KCurrent reportDirectors or officers changed
- Sep 30, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
- Aug 27, 202610-QQuarterly report · period to Jul 2026
- Aug 27, 20268-KCurrent reportResults of operations
- Jun 26, 20268-KCurrent reportShareholder vote
- May 28, 202610-QQuarterly report · period to Apr 2026
- May 28, 20268-KCurrent reportResults of operations
- May 13, 2026DEF 14AProxy statement
- May 8, 20268-KCurrent reportDirectors or officers changed
- Apr 6, 20268-KCurrent reportDirectors or officers changed
- Mar 30, 20268-KCurrent reportDirectors or officers changed · Regulation FD disclosure
- Mar 17, 202610-KAnnual report · period to Jan 2026
Official filings of HealthEquity, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $1.3 B
- Operating income
- $322 M
- Net income
- $215 M
For year ending January-2026 · source: SEC filing
Balance sheet
- Total assets
- $3.4 B
- Total liabilities
- $1.3 B
- Total equity
- $2.1 B
As of January-2026
HEALTHEQUITY - Yearly Revenue and Net Income - in Million USD
Balance sheet
Total Assets as on Jan-2023 was 3,088 Million USD.
Total Liabilities as on Jan-2023 was 1,193 Million USD.
Total Equity as on Jan-2023 was 1,895 Million USD
Top 100 institutional investors in HealthEquity, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11,301,328 | +23,414 (+0.21%) | 13.66% | $1000 M | Nov 13, 2026 |
| 2 | Wasatch Advisors LP | 7,011,469 | -949,266 (-11.92%) | 8.48% | $620 M | Oct 13, 2026 |
| 3 | Vanguard Portfolio Management LLC | 3,951,899 | -105,744 (-2.61%) | 4.78% | $350 M | Nov 13, 2026 |
| 4 | Morgan Stanley | 3,806,596 | -740,623 (-16.29%) | 4.60% | $337 M | Nov 13, 2026 |
| 5 | Vanguard Capital Management LLC | 3,575,041 | -65,735 (-1.81%) | 4.32% | $316 M | Nov 13, 2026 |
| 6 | State Street Corp | 3,242,217 | +1,171 (+0.04%) | 3.92% | $287 M | Nov 12, 2026 |
| 7 | Geode Capital Management, LLC | 2,327,557 | -46,910 (-1.98%) | 2.81% | $206 M | Nov 6, 2026 |
| 8 | Dimensional Fund Advisors LP | 1,896,816 | +27,780 (+1.49%) | 2.29% | $168 M | Nov 4, 2026 |
| 9 | William Blair Investment Management, LLC | 1,740,078 | -33,149 (-1.87%) | 2.10% | $154 M | Nov 6, 2026 |
| 10 | Arrowstreet Capital, Limited Partnership | 1,513,755 | +547,948 (+56.73%) | 1.83% | $134 M | Nov 13, 2026 |
| 11 | Price T Rowe Associates Inc /MD/ | 1,458,293 | +463,742 (+46.63%) | 1.76% | $129 M | Nov 16, 2026 |
| 12 | Westfield Capital Management Co LP | 1,436,437 | +733,124 (+104.24%) | 1.74% | $127 M | Nov 12, 2026 |
| 13 | Swedbank AB | 1,403,000 | +551,600 (+64.79%) | 1.70% | $124 M | Oct 27, 2026 |
| 14 | Bank Of America Corp /de/ | 1,399,811 | +253,076 (+22.07%) | 1.69% | $124 M | Nov 16, 2026 |
| 15 | Goldman Sachs Group Inc | 1,283,552 | +276,118 (+27.41%) | 1.55% | $114 M | Nov 16, 2026 |
| 16 | Brown Advisory Inc | 1,272,182 | -100,442 (-7.32%) | 1.54% | $113 M | Nov 16, 2026 |
| 17 | Charles Schwab Investment Management Inc | 1,240,039 | +51,137 (+4.30%) | 1.50% | $110 M | Nov 16, 2026 |
| 18 | AQR Capital Management LLC | 1,182,136 | -817,073 (-40.87%) | 1.43% | $105 M | Nov 16, 2026 |
| 19 | Clearbridge Investments, LLC | 1,154,627 | -142,138 (-10.96%) | 1.40% | $102 M | Nov 12, 2026 |
| 20 | FMR LLC | 1,152,331 | -386,056 (-25.09%) | 1.39% | $102 M | Nov 10, 2026 |
| 21 | Geneva Capital Management LLC | 1,106,066 | -43,614 (-3.79%) | 1.34% | $98 M | Nov 9, 2026 |
| 22 | Northern Trust Corp | 1,032,212 | -39,907 (-3.72%) | 1.25% | $91 M | Nov 16, 2026 |
| 23 | Artisan Partners Limited Partnership | 1,026,017 | +641,910 (+167.12%) | 1.24% | $91 M | Nov 13, 2026 |
| 24 | Greenhouse Funds LLLP | 1,002,314 | -180,710 (-15.28%) | 1.21% | $89 M | Nov 16, 2026 |
| 25 | GW&K Investment Management, LLC | 989,427 | +357,045 (+56.46%) | 1.20% | $88 M | Nov 10, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Stephens Investment Management Group LLC | 976,998 | +247,918 (+34.00%) | 1.18% | $86 M | Nov 10, 2026 |
| 27 | Loomis Sayles & Co L P | 963,446 | +54,892 (+6.04%) | 1.16% | $85 M | Nov 12, 2026 |
| 28 | DAVENPORT & Co LLC | 962,799 | -124,419 (-11.44%) | 1.16% | $85 M | Oct 14, 2026 |
| 29 | Jpmorgan Chase & Co | 887,095 | -271,742 (-23.45%) | 1.07% | $78 M | Nov 12, 2026 |
| 30 | Janus Henderson Group Ltd. | 871,305 | — | 1.05% | $77 M | Nov 16, 2026 |
| 31 | American Century Companies Inc | 855,483 | +95,505 (+12.57%) | 1.03% | $76 M | Nov 12, 2026 |
| 32 | Nuveen, LLC | 748,998 | +16,248 (+2.22%) | 0.91% | $66 M | Nov 10, 2026 |
| 33 | Bamco Inc /ny/ | 700,394 | -50,000 (-6.66%) | 0.85% | $62 M | Nov 16, 2026 |
| 34 | Bank of New York Mellon Corp | 692,832 | +26,572 (+3.99%) | 0.84% | $61 M | Nov 5, 2026 |
| 35 | SEI Investments Co | 690,818 | +7,498 (+1.10%) | 0.84% | $61 M | Nov 10, 2026 |
| 36 | Nomura Asset Management International Inc. | 657,982 | -20,555 (-3.03%) | 0.80% | $58 M | Nov 16, 2026 |
| 37 | Vanguard Fiduciary Trust Co | 594,088 | -7,736 (-1.29%) | 0.72% | $53 M | Nov 13, 2026 |
| 38 | UBS Group AG | 525,929 | +90,472 (+20.78%) | 0.64% | $47 M | Nov 10, 2026 |
| 39 | Park West Asset Management LLC | 477,917 | -298,734 (-38.46%) | 0.58% | $42 M | Nov 16, 2026 |
| 40 | Citadel Advisors LLC | 465,000 | -217,961 (-31.91%) | 0.56% | $41 M | Nov 16, 2026 |
| 41 | Raymond James Financial Inc | 448,981 | +17,014 (+3.94%) | 0.54% | $40 M | Nov 12, 2026 |
| 42 | Wellington Management Group LLP | 415,241 | +27,347 (+7.05%) | 0.50% | $37 M | Nov 16, 2026 |
| 43 | Franklin Templeton Inc | 375,237 | +14,578 (+4.04%) | 0.45% | $33 M | Nov 12, 2026 |
| 44 | Kayne Anderson Rudnick Investment Management LLC | 362,297 | -38,316 (-9.56%) | 0.44% | $32 M | Nov 13, 2026 |
| 45 | Principal Financial Group Inc | 361,622 | +43,057 (+13.52%) | 0.44% | $32 M | Nov 2, 2026 |
| 46 | Segall Bryant & Hamill, LLC | 356,341 | +118,098 (+49.57%) | 0.43% | $32 M | Nov 16, 2026 |
| 47 | Oberweis Asset Management Inc/ | 337,698 | +109,407 (+47.92%) | 0.41% | $30 M | Nov 16, 2026 |
| 48 | 12th Street Asset Management Company, LLC | 319,442 | -25,948 (-7.51%) | 0.39% | $28 M | Nov 12, 2026 |
| 49 | Lazard Asset Management LLC | 305,607 | +29,914 (+10.85%) | 0.37% | $27 M | Nov 16, 2026 |
| 50 | CIBC Bancorp USA Inc. | 303,650 | -7,745 (-2.49%) | 0.37% | $27 M | Nov 13, 2026 |
| 51 | DF Dent & Co Inc | 290,244 | +43,112 (+17.44%) | 0.35% | $26 M | Nov 16, 2026 |
| 52 | Point72 Asset Management, L.P. | 282,863 | New | 0.34% | $25 M | Nov 16, 2026 |
| 53 | Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 275,817 | -181,105 (-39.64%) | 0.33% | $24 M | Nov 12, 2026 |
| 54 | Aristotle Capital Boston, LLC | 268,343 | -64,541 (-19.39%) | 0.32% | $24 M | Nov 16, 2026 |
| 55 | Portolan Capital Management, LLC | 265,049 | +175,775 (+196.89%) | 0.32% | $23 M | Nov 16, 2026 |
| 56 | Public Sector Pension Investment Board | 259,970 | +119,018 (+84.44%) | 0.31% | $23 M | Nov 10, 2026 |
| 57 | Rhumbline Advisers | 251,638 | -2,765 (-1.09%) | 0.30% | $22 M | Nov 10, 2026 |
| 58 | Ashford Capital Management Inc | 250,446 | -2,995 (-1.18%) | 0.30% | $22 M | Nov 16, 2026 |
| 59 | Barclays PLC | 248,409 | +211,966 (+581.64%) | 0.30% | $22 M | Nov 6, 2026 |
| 60 | Envestnet Asset Management Inc | 230,951 | +55,769 (+31.83%) | 0.28% | $20 M | Nov 16, 2026 |
| 61 | USS Investment Management Ltd | 230,597 | New | 0.28% | $20 M | Nov 10, 2026 |
| 62 | Oppenheimer Asset Management Inc. | 226,704 | -6,674 (-2.86%) | 0.27% | $20 M | Oct 27, 2026 |
| 63 | Ranger Investment Management, L.P. | 221,323 | -97,930 (-30.67%) | 0.27% | $20 M | Nov 6, 2026 |
| 64 | Retirement Systems of Alabama | 220,184 | +23,906 (+12.18%) | 0.27% | $19 M | Nov 4, 2026 |
| 65 | Allspring Global Investments Holdings, LLC | 219,109 | +16,418 (+8.10%) | 0.26% | $19 M | Nov 4, 2026 |
| 66 | Alliancebernstein L.P. | 218,582 | -3,898 (-1.75%) | 0.26% | $19 M | Nov 16, 2026 |
| 67 | Glenmede Trust Co NA | 213,697 | +39,830 (+22.91%) | 0.26% | $19 M | Nov 16, 2026 |
| 68 | Royal Bank Of Canada | 209,161 | -3,103 (-1.46%) | 0.25% | $19 M | Nov 16, 2026 |
| 69 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 200,848 | +7,356 (+3.80%) | 0.24% | $18 M | Nov 16, 2026 |
| 70 | Invesco Ltd. | 196,354 | -1,741 (-0.88%) | 0.24% | $17 M | Nov 12, 2026 |
| 71 | D. E. Shaw & Co., Inc. | 180,292 | +159,861 (+782.44%) | 0.22% | $16 M | Nov 16, 2026 |
| 72 | Frontier Capital Management Co LLC | 173,142 | -11,166 (-6.06%) | 0.21% | $15 M | Nov 16, 2026 |
| 73 | Qube Research & Technologies Ltd | 172,161 | +15,610 (+9.97%) | 0.21% | $15 M | Nov 13, 2026 |
| 74 | Wells Fargo & Company/mn | 170,443 | -19,982 (-10.49%) | 0.21% | $15 M | Nov 16, 2026 |
| 75 | Swiss National Bank | 169,100 | -400 (-0.24%) | 0.20% | $15 M | Nov 12, 2026 |
| 76 | California Public Employees Retirement System | 150,493 | -4,826 (-3.11%) | 0.18% | $13 M | Nov 16, 2026 |
| 77 | Axiom Investors LLC /de | 139,014 | +18,103 (+14.97%) | 0.17% | $12 M | Nov 12, 2026 |
| 78 | Premier Fund Managers Ltd | 138,731 | -6,512 (-4.48%) | 0.17% | $12 M | Nov 2, 2026 |
| 79 | Russell Investments Group, Ltd. | 129,582 | -27,204 (-17.35%) | 0.16% | $11 M | Nov 6, 2026 |
| 80 | Castleark Management LLC | 129,080 | +1,310 (+1.03%) | 0.16% | $11 M | Nov 17, 2026 |
| 81 | One Way Holdings LLC | 128,873 | -8,219 (-6.00%) | 0.16% | $11 M | Oct 29, 2026 |
| 82 | Peregrine Capital Management LLC | 128,178 | -4,513 (-3.40%) | 0.15% | $11 M | Nov 9, 2026 |
| 83 | Deutsche Bank AG\ | 126,907 | -5,798 (-4.37%) | 0.15% | $11 M | Nov 6, 2026 |
| 84 | Legal & General Group Plc | 122,905 | +4,383 (+3.70%) | 0.15% | $11 M | Nov 16, 2026 |
| 85 | Ensign Peak Advisors, Inc | 116,756 | -525 (-0.45%) | 0.14% | $10 M | Nov 12, 2026 |
| 86 | Prosight Management, LP | 115,796 | New | 0.14% | $10 M | Nov 13, 2026 |
| 87 | Victory Capital Management Inc | 112,990 | +23,523 (+26.29%) | 0.14% | $10 M | Nov 10, 2026 |
| 88 | Wealthspire Advisors, LLC | 110,970 | -1,016 (-0.91%) | 0.13% | $10 M | Nov 13, 2026 |
| 89 | Tectonic Advisors LLC | 109,953 | +9,630 (+9.60%) | 0.13% | $10 M | Oct 22, 2026 |
| 90 | HRT Financial LP | 109,455 | New | 0.13% | $10 M | Nov 13, 2026 |
| 91 | Voya Investment Management LLC | 108,771 | +14,140 (+14.94%) | 0.13% | $10 M | Nov 10, 2026 |
| 92 | Bessemer Group Inc | 106,777 | -1,911 (-1.76%) | 0.13% | $9 M | Nov 9, 2026 |
| 93 | B. Metzler seel. Sohn & Co. AG | 102,322 | -8,786 (-7.91%) | 0.12% | $9 M | Oct 30, 2026 |
| 94 | Ameriprise Financial Inc | 100,687 | -25,195 (-20.01%) | 0.12% | $9 M | Nov 16, 2026 |
| 95 | Nordea Investment Management AB | 100,332 | +18,648 (+22.83%) | 0.12% | $9 M | Nov 9, 2026 |
| 96 | Beacon Investment Advisory Services, Inc. | 96,556 | +2,319 (+2.46%) | 0.12% | $9 M | Oct 13, 2026 |
| 97 | California State Teachers Retirement System | 96,070 | -1,724 (-1.76%) | 0.12% | $8 M | Nov 13, 2026 |
| 98 | Renaissance Group LLC | 94,315 | -2,524 (-2.61%) | 0.11% | $8 M | Nov 12, 2026 |
| 99 | Channing Capital Management, LLC | 92,409 | New | 0.11% | $8 M | Nov 2, 2026 |
| 100 | Danske Bank A/s | 92,029 | New | 0.11% | $8 M | Nov 9, 2026 |
Mutual funds holding HealthEquity, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 iShares Core S&P Mid-Cap ETFBlackRock Fund Advisors | 2.89 M | $261 M | 3.5% | 0.21% | +2.2% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 2.52 M | $228 M | 3.1% | <0.01% | −7.0% | Jun 30, 2026 |
| 🇺🇸 Wasatch Core Growth FundWasatch Advisors LP | 2.23 M | $201 M | 2.7% | 6.7% | +20% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 2.18 M | $197 M | 2.6% | 0.24% | +5.7% | Jun 30, 2026 |
| 🇺🇸 Vanguard Small-Cap Index FundThe Vanguard Group, Inc. | 1.82 M | $165 M | 2.2% | 0.09% | −7.5% | Jun 30, 2026 |
| 🇺🇸 Eaton Vance Atlanta Capital SMID-Cap FundBoston Management and Research | 1.49 M | $134 M | 1.8% | 1.5% | +142% | Jun 30, 2026 |
| 🇺🇸 Vanguard Small-Cap Growth Index FundThe Vanguard Group, Inc. | 1.05 M | $95 M | 1.3% | 0.20% | −4.8% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 927,272 | $93 M | 1.1% | 0.27% | +11% | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 969,218 | $88 M | 1.2% | 0.09% | +1.6% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 783,398 | $71 M | 0.95% | 0.46% | +14% | Jun 30, 2026 |
| 🇺🇸 Wasatch Small Cap Growth FundWasatch Advisors LP | 752,084 | $68 M | 0.91% | 5.8% | +9.2% | Jun 30, 2026 |
| 🇺🇸 Baron Small Cap FundBAMCO, Inc. | 750,000 | $68 M | 0.91% | 2.4% | no change | Jun 30, 2026 |
| 🇺🇸 State Street SPDR S&P MidCap 400SM ETF TrustSpdr S&P Midcap 400 ETF Trust | 649,983 | $59 M | 0.79% | 0.21% | +0.9% | Jun 30, 2026 |
| 🇺🇸 Small Cap Growth FundAmerican Century Investment Management, Inc. | 575,511 | $58 M | 0.70% | 1.0% | +2.6% | Jul 31, 2026 |
| 🇺🇸 ClearBridge Select FundFRANKLIN TEMPLETON FUND ADVISER, LLC | 488,386 | $49 M | 0.59% | 1.5% | −6.6% | Jul 31, 2026 |
| 🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc. | 476,716 | $48 M | 0.58% | 0.22% | +15% | Jul 31, 2026 |
| 🇺🇸 iShares S&P Mid-Cap 400 Growth ETFBlackRock Fund Advisors | 505,806 | $46 M | 0.61% | 0.40% | −2.7% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Integrated U.S. Small-Cap Growth Equity FundT. Rowe Price Associates, Inc. | 449,983 | $41 M | 0.54% | 0.41% | no change | Jun 30, 2026 |
| 🇸🇪 Swedbank Robur Transfer 70Swedbank Robur Fonder AB | 437,300 | $39 M | 0.53% | 0.34% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 439,329 | $39 M | 0.53% | 0.09% | −3.0% | May 31, 2026 |
| 🇺🇸 State Street SPDR Portfolio S&P 400 Mid Cap ETFSSGA Funds Management, Inc. | 427,626 | $39 M | 0.52% | 0.21% | +2.5% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 433,127 | $38 M | 0.52% | 0.22% | +2.4% | May 31, 2026 |
| 🇺🇸 Janus Henderson Triton FundJanus Investment Fund | 418,746 | $38 M | 0.51% | 0.64% | +1.7% | Jun 30, 2026 |
| 🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC | 416,088 | $38 M | 0.50% | 0.65% | +12% | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 367,698 | $37 M | 0.44% | 0.19% | no change | Jul 31, 2026 |
| 🇺🇸 Wasatch Small Cap Value FundWasatch Advisors LP | 405,271 | $37 M | 0.49% | 2.6% | +1.3% | Jun 30, 2026 |
| 🇺🇸 ClearBridge Small Cap Growth FundFRANKLIN TEMPLETON FUND ADVISER, LLC | 360,320 | $36 M | 0.44% | 1.9% | no change | Jul 31, 2026 |
| 🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc. | 410,182 | $36 M | 0.50% | 0.16% | −2.0% | May 31, 2026 |
| 🇺🇸 Harbor Small Cap Growth FundHarbor Capital Advisors, Inc. | 346,177 | $35 M | 0.42% | 1.3% | +5.8% | Jul 31, 2026 |
| 🇺🇸 JPMorgan Small Cap Equity FundJ.P. Morgan Investment Management Inc. | 368,976 | $33 M | 0.45% | 1.2% | −7.6% | Jun 30, 2026 |
| 🇺🇸 Franklin Small Cap Growth FundFranklin Advisers, Inc. | 308,622 | $31 M | 0.37% | 1.3% | +5.6% | Jul 31, 2026 |
| 🇺🇸 Davenport Equity Opportunities FundDavenport & Company LLC | 310,310 | $28 M | 0.38% | 3.5% | +13% | Jun 30, 2026 |
| 🇺🇸 Davenport Small Cap Focus FundDavenport & Company LLC | 304,228 | $27 M | 0.37% | 4.4% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 270,563 | $27 M | 0.33% | 0.18% | +3.4% | Jul 31, 2026 |
| 🇺🇸 Nomura Small Cap Core FundDelaware Management Company | 292,177 | $26 M | 0.35% | 0.47% | −4.1% | May 29, 2026 |
| 🇸🇪 Swedbank Robur Transfer 80Swedbank Robur Fonder AB | 269,000 | $24 M | 0.33% | 0.21% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth FundFidelity Management & Research Company LLC | 235,933 | $24 M | 0.29% | 0.27% | no change | Jul 31, 2026 |
| 🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC | 255,125 | $23 M | 0.31% | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 Nationwide Geneva Small Cap Growth FundNATIONWIDE FUND ADVISORS | 227,629 | $23 M | 0.28% | 2.6% | −12% | Jul 31, 2026 |
| 🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc. | 256,670 | $23 M | 0.31% | 0.12% | −0.8% | May 31, 2026 |
| 🇺🇸 Loomis Sayles Small Cap Growth FundLoomis, Sayles & Company, L.P. | 245,432 | $22 M | 0.30% | 0.98% | −9.7% | Jun 30, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 208,666 | $21 M | 0.25% | 0.85% | +4.5% | Jul 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 206,104 | $21 M | 0.25% | 0.27% | +11% | Jul 31, 2026 |
| 🇺🇸 Schwab U.S. Mid-Cap ETFCharles Schwab Investment Management, Inc. | 230,781 | $20 M | 0.28% | 0.14% | −1.0% | May 31, 2026 |
| 🇺🇸 Wasatch Ultra Growth FundWasatch Advisors LP | 224,032 | $20 M | 0.27% | 4.4% | no change | Jun 30, 2026 |
| 🇺🇸 Morgan Stanley Discovery PortfolioBrighthouse Investment Advisers, LLC | 221,210 | $20 M | 0.27% | 1.6% | +13% | Jun 30, 2026 |
| 🇺🇸 Janus Henderson Venture FundJanus Investment Fund | 215,922 | $20 M | 0.26% | 0.54% | +3.6% | Jun 30, 2026 |
| 🇺🇸 Brown Advisory Small-Cap Growth FundBROWN ADVISORY LLC | 214,956 | $19 M | 0.26% | 3.3% | −4.2% | Jun 30, 2026 |
| 🇺🇸 JNL Multi-Manager Small Cap Growth FundJackson National Asset Management, LLC | 204,688 | $18 M | 0.25% | 0.73% | −34% | Jun 30, 2026 |
| 🇺🇸 AQR Long-Short Equity FundAQR CAPITAL MANAGEMENT, LLC | 203,143 | $18 M | 0.25% | 0.23% | −45% | Jun 30, 2026 |
| 🇺🇸 Oberweis Small-Cap Opportunities FundOberweis Asset Management, Inc. | 194,200 | $18 M | 0.23% | 0.62% | +40% | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 196,608 | $17 M | 0.24% | 0.02% | +3.1% | May 31, 2026 |
| 🇺🇸 Fidelity Stock Selector Small Cap FundFidelity Management & Research Company LLC | 151,100 | $15 M | 0.18% | 0.21% | +15% | Jul 31, 2026 |
| 🇺🇸 Small Cap Equity PortfolioGlenmede Investment Management LP | 149,101 | $15 M | 0.18% | 1.4% | −5.5% | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 149,037 | $15 M | 0.18% | 0.03% | +2.4% | Jul 31, 2026 |
| 🇺🇸 William Blair Small Cap Growth FundWilliam Blair Investment Management, LLC | 163,750 | $15 M | 0.20% | 1.2% | +46% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 161,294 | $14 M | 0.19% | 0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 156,460 | $14 M | 0.19% | 0.24% | +14% | Jun 30, 2026 |
| 🇺🇸 William Blair Small-Mid Cap Growth FundWilliam Blair Investment Management, LLC | 155,800 | $14 M | 0.19% | 1.1% | −0.6% | Jun 30, 2026 |
| 🇺🇸 iShares U.S. Healthcare Providers ETFBlackRock Fund Advisors | 148,817 | $13 M | 0.18% | 1.1% | +48% | Jun 30, 2026 |
| 🇺🇸 Nomura Small Cap Growth FundDelaware Management Company | 146,690 | $13 M | 0.18% | 1.1% | +22% | Jun 30, 2026 |
| 🇺🇸 Discovery PortfolioMorgan Stanley Investment Management Inc. | 146,577 | $13 M | 0.18% | 1.7% | +12% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Small Cap Growth FundJ.P. Morgan Investment Management Inc. | 138,042 | $12 M | 0.17% | 0.48% | −5.0% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth K6 FundFidelity Management & Research Company LLC | 119,638 | $12 M | 0.14% | 0.26% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard S&P Mid-Cap 400 Index FundThe Vanguard Group, Inc. | 136,309 | $12 M | 0.16% | 0.21% | +3.9% | May 31, 2026 |
| 🇺🇸 State Street SPDR S & P 400 Mid Cap Growth ETFSSGA Funds Management, Inc. | 130,609 | $12 M | 0.16% | 0.40% | +0.4% | Jun 30, 2026 |
| 🇺🇸 Virtus KAR Mid-Cap Growth FundVirtus Equity Trust | 127,212 | $11 M | 0.15% | 2.8% | −9.6% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 130,285 | $11 M | 0.16% | 0.01% | +2.3% | May 31, 2026 |
| 🇺🇸 AMG GW&K Small Cap Core FundAMG Funds LLC | 123,535 | $11 M | 0.15% | 1.4% | +53% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 110,689 | $11 M | 0.13% | 0.27% | +11% | Jul 31, 2026 |
| 🇺🇸 Artisan Small Cap FundArtisan Partners Limited Partnership | 122,416 | $11 M | 0.15% | 1.2% | +39% | Jun 30, 2026 |
| 🇺🇸 Principal U.S. Small-Cap ETFPrincipal Global Investors, LLC | 119,817 | $11 M | 0.14% | 0.46% | +9.5% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 118,455 | $11 M | 0.14% | 2.3% | +14% | Jun 30, 2026 |
| 🇺🇸 Old Westbury Small & Mid Cap Strategies FundBessemer Investment Management LLC | 105,925 | $11 M | 0.13% | 0.12% | −41% | Jul 31, 2026 |
| 🇺🇸 Inception PortfolioMorgan Stanley Investment Management Inc. | 112,651 | $10 M | 0.14% | 3.6% | +16% | Jun 30, 2026 |
| 🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 110,811 | $10 M | 0.13% | 0.01% | −0.3% | Jun 30, 2026 |
| 🇺🇸 ClearBridge Small Cap FundFRANKLIN TEMPLETON FUND ADVISER, LLC | 99,465 | $10 M | 0.12% | 1.4% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP | 97,220 | $10 M | 0.12% | 0.03% | no change | Jul 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 106,276 | $10 M | 0.13% | 0.09% | +4.8% | Jun 30, 2026 |
| 🇺🇸 NYLIM VP Small Cap Growth PortfolioNew York Life Investment Management LLC | 103,433 | $9 M | 0.13% | 2.2% | +1.3% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Small Cap Opportunities FundFidelity Management & Research Company LLC | 86,700 | $9 M | 0.10% | 0.18% | −11% | Jul 31, 2026 |
| 🇺🇸 Strategic Advisers Fidelity U.S. Total Stock FundStrategic Advisers LLC | 98,513 | $9 M | 0.12% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Applied Finance Explorer FundApplied Finance Advisors, LLC | 85,707 | $9 M | 0.10% | 0.82% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Targeted Value ETFDimensional Fund Advisors LP | 85,269 | $9 M | 0.10% | 0.06% | +188% | Jul 31, 2026 |
| 🇺🇸 Morningstar U.S. Equity FundMorningstar Investment Management LLC | 84,154 | $8 M | 0.10% | 0.44% | +25% | Jul 31, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 95,272 | $8 M | 0.12% | 0.16% | +119% | May 29, 2026 |
| 🇺🇸 U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 83,089 | $8 M | 0.10% | 0.05% | +139% | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 92,092 | $8 M | 0.11% | 0.22% | +4.6% | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 79,518 | $8 M | 0.10% | 0.01% | +7.8% | Jul 31, 2026 |
| 🇺🇸 Allspring Common Stock FundAllspring Funds Management, LLC | 87,671 | $8 M | 0.11% | 1.2% | −22% | Jun 30, 2026 |
| 🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP | 78,247 | $8 M | 0.09% | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 JNL Mid Cap Index FundJackson National Asset Management, LLC | 85,708 | $8 M | 0.10% | 0.21% | −0.2% | Jun 30, 2026 |
| 🇺🇸 AQR Equity Market Neutral FundAQR CAPITAL MANAGEMENT, LLC | 83,988 | $8 M | 0.10% | 0.26% | −33% | Jun 30, 2026 |
| 🇺🇸 Vanguard S&P Mid-Cap 400 Growth Index FundThe Vanguard Group, Inc. | 85,672 | $8 M | 0.10% | 0.41% | +9.0% | May 31, 2026 |
| 🇺🇸 Nationwide Geneva Mid Cap Growth FundNATIONWIDE FUND ADVISORS | 73,159 | $7 M | 0.09% | 2.8% | +30% | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Marketwide Value ETFDimensional Fund Advisors LP | 72,205 | $7 M | 0.09% | 0.05% | +0.7% | Jul 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 79,524 | $7 M | 0.10% | 0.46% | +24% | Jun 30, 2026 |
| 🇺🇸 ClearBridge Variable Small Cap Growth PortfolioFRANKLIN TEMPLETON FUND ADVISER, LLC | 78,332 | $7 M | 0.09% | 1.5% | +2.4% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 79,126 | $7 M | 0.10% | 0.41% | +1.2% | May 31, 2026 |
| 🇺🇸 Fidelity Enhanced Large Cap Core ETFFidelity Management & Research Company LLC | 76,575 | $7 M | 0.09% | 0.09% | +957088% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at HealthEquity, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Sunil RajasekarEVP Chief Prod & Strat Officer | Buy | +108 | $90.33 | $10 K | 53,405 | Form 4 |
| filed | Stephen NeelemanFOUNDER AND VICE CHAIRMAN, Director | Shares withheld for tax | -1,095 | $91.16 | $100 K | 136,470 | Form 4 |
| filed | James M. LucaniaEVP & CFO | Shares withheld for tax | -2,822 | $91.16 | $257 K | 101,795 | Form 4 |
| filed | Delano LaddEVP, General Counsel | Shares withheld for tax | -1,080 | $91.16 | $98 K | 88,974 | Form 4 |
| filed | Scott CutlerPresident and CEO, Director | Shares withheld for tax | -1,230 | $91.16 | $112 K | 175,175 | Form 4 |
| filed | Michael Henry FioreFormer EVP, CCO | Shares withheld for tax | -2,032 | $91.16 | $185 K | 50,212 | Form 4 |
| filed | Michael GathrightChief Customer Officer | Shares withheld for tax | -662 | $91.16 | $60 K | 39,231 | Form 4 |
| filed | Stephen NeelemanFOUNDER AND VICE CHAIRMAN, Director | Giftindirect | -1,500 | — | — | 408,235 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: HealthEquity, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q2 2027 | $107.7M |
| Q2 2026 | Q1 2027 | $123.3M |
| Q1 2026 | Q4 2026 | $81M |
| Q4 2025 | Q3 2026 | $92.4M |
| Q3 2025 | Q2 2026 | $66.7M |
| Q2 2025 | Q1 2026 | $59.1M |
| Q1 2025 | Q4 2025 | $63M |
| Q4 2024 | Q3 2025 | $58.5M |
| Q3 2024 | Q2 2026 | $0M |
| Q2 2024 | Q1 2026 | $0M |
| Q1 2024 | Q4 2025 | $0M |
Fails to deliver
- : 1,124 shares at $100.88
- : 18,561 shares at $103.97
- : 536 shares at $96.60
- : 6,039 shares at $90.19
- : 67 shares at $91.90
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
HealthEquity, Inc. scorecard#
Passes 19 of the 26 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (2 of 6). Fiscal year 2025; market cap of Oct 28, 2026.
Valuation2 of 6
- ✗P/E below its peers' median35.3×P/E 35.3× against Healthcare's median of 30.0×.
- ✗Price to book below its peers' median4.0×Price to book 4.0× against Healthcare Information Services's median of 1.9×.
- ✗Price to sales below its peers' median6.1×Price to sales 6.1× against Healthcare Information Services's median of 1.7×.
- ✓Free cash flow yield above 5%5.5%Free cash flow is 5.5% of the market value.
- ✗Earnings yield above the 10-year Treasury yield2.8%Earnings yield 2.8% against the 10-year Treasury's 5.15% on 2026-11-13.
- ✓The price assumes slower growth than the last three years'11.6%The price assumes 11.6% a year for ten years; revenue grew 15.1% a year over the last three.
Growth6 of 6
- ✓Revenue grew in the newest year9.5%Revenue up 9.5% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years15.1%15.1% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median15.1%15.1% a year against Healthcare Information Services's median of 6.1% (27 companies).
- ✓Earnings per share grew in the newest year2.46 vs 1.09Diluted EPS 2.46 in fiscal 2025 against 1.09 the year before (report's currency).
- ✓Net income higher than five years earlier$215 M$215 M in fiscal 2025 against $9 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability3 of 6
- ✓Profitable in the newest year$215 MNet income $215 M in fiscal 2025.
- ✗Profitable in each of the last five years3 of 5Profitable in 3 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median24.6%24.6% against Healthcare Information Services's median of -7.1% (29 companies).
- ✗Return on equity above 15%10.2%10.2% in fiscal 2025.
- ✗Return on invested capital above 10%8.9%8.9% in fiscal 2025.
- ✓Operating margin wider than three years earlier24.6%24.6% in fiscal 2025 against 1.1% in 2022.
Financial health5 of 5
- ✓Short-term assets cover short-term liabilities3.3×Current ratio 3.27 at the end of fiscal 2025.
- ✓Debt below equity0.5×Debt to equity 0.45 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDA1.3×Net debt 1.3 times EBITDA in fiscal 2025.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✓Altman Z-score outside the distress zone4.84Z-score 4.84 (safe zone) for fiscal 2025.
Shareholder returns3 of 3
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-1.5%Diluted shares down 1.5% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.6%Dividends and buybacks were 3.6% of the market value.
- ✓Free cash flow covers dividends and buybacks$455 MFree cash flow $455 M against $299 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from HealthEquity, Inc.'s statements, beside the median of Healthcare Information Services.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 24.6% | -7.1% | |
| Net margin | 16.4% | -6.8% | |
| Return on equity | 10.2% | -0.8% | |
| Revenue growth, 3 years a year | 15.1% | 6.1% | |
| Revenue growth | 9.5% | 8.7% | |
| Debt to equity | 0.45× | 0.62× |
9of 9on the Piotroski tests of financial strength
- Goodwill and intangibles ($2.7 billion) exceed shareholders' equity ($2.1 billion).
- Revenue has grown 13 years in a row.
- Free cash flow has been positive 14 years in a row.
HealthEquity, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Jan 31, 2026 | FY 2024to Jan 31, 2025 | FY 2023to Jan 31, 2024 | FY 2022to Jan 31, 2023 | FY 2021to Jan 31, 2022 | FY 2020to Jan 31, 2021 | FY 2019to Jan 31, 2020 | FY 2018to Jan 31, 2019 | FY 2017to Jan 31, 2018 | FY 2016to Jan 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 1,313+9.5%100% | 1,200+20.0%100% | 1,000+16.0%100% | 862+13.9%100% | 757+3.1%100% | 734+37.9%100% | 532+85.2%100% | 287+25.1%100% | 230+28.7%100% | 178—100% | |
| Cost of revenue | 400−5.3%30.5% | 423+12.1%35.2% | 377+1.9%37.7% | 370r372+11.5%42.9% | 332r333+4.3%43.9% | 318+54.4%43.4% | 206+94.3%38.7% | 106+12.1%36.9% | 95+31.4%41.2% | 72—40.4% | |
| Gross profit | 913+17.5%69.5% | 777+24.8%64.8% | 623+26.6%62.3% | 492r490+15.8%57.1% | 425r424+2.3%56.1% | 415+27.4%56.6% | 326+79.9%61.3% | 181+34.3%63.1% | 135+26.9%58.8% | 106—59.6% | |
| Research and development | 263+9.6%20.0% | 240+9.5%20.0% | 219+13.2%21.9% | 193+22.9%22.4% | 157+26.1%20.8% | 125+60.9%17.0% | 78+121%14.6% | 35+28.0%12.2% | 27+22.4%11.9% | 22—12.5% | |
| Selling and marketing | 95+5.0%7.3% | 91+14.5%7.6% | 79+15.1%7.9% | 69+17.5%8.0% | 59+17.3%7.7% | 50+13.7%6.8% | 44+49.0%8.3% | 29+27.5%10.3% | 23+26.3%10.1% | 18—10.3% | |
| General and administrative | 120−9.3%9.1% | 132+27.6%11.0% | 104+6.3%10.4% | 97r96+14.1%11.3% | 85r84+1.1%11.3% | 84+39.5%11.5% | 61+83.3%11.4% | 33+31.6%11.5% | 25+24.6%10.9% | 20—11.3% | |
| Operating expenses | 591−3.9%45.0% | 615+21.8%51.3% | 505+4.6%50.5% | 483r481+7.5%56.0% | 449r448+17.7%59.3% | 381+53.2%52.0% | 249+140%46.8% | 104+28.6%36.0% | 80+23.6%35.1% | 65—36.5% | |
| Operating income | 322+98.6%24.6% | 162+37.9%13.5% | 118+1200%11.8% | 9.1—1.1% | −24−171%−3.2% | 34−55.8%4.6% | 77−0.9%14.5% | 78+42.7%27.0% | 54+32.0%23.7% | 41—23.1% | |
| Interest expense and finance costs | 57−5.8%4.3% | 61+9.3%5.1% | 55+14.5%5.5% | 48+32.4%5.6% | 37+4.8%4.8% | 35+40.8%4.8% | 25+9075%4.7% | 0.3−1.5%0.1% | 0.3—0.1% | — | |
| Other non-operating income (expense) | −45—−3.4% | −46—−3.9% | −43—−4.3% | −47—−5.5% | −43—−5.6% | −30—−4.1% | −34—−6.4% | −1.9—−0.6% | −2.2—−1.0% | −1.1—−0.6% | |
| Income before tax | 277+139%21.1% | 116+54.6%9.7% | 75—7.5% | −38—−4.4% | −67−1712%−8.8% | 4.1−90.4%0.6% | 43−43.1%8.1% | 76+45.3%26.4% | 52+30.1%22.7% | 40—22.5% | |
| Income tax | 62+222%4.7% | 19+0.0%1.6% | 19—1.9% | −12—−1.4% | −22—−3.0% | −4.7−234%−0.6% | 3.5+81.9%0.7% | 1.9−60.2%0.7% | 4.8−64.9%2.1% | 14—7.7% | |
| Net income attributable to shareholders | 215+123%16.4% | 97+73.6%8.1% | 56—5.6% | −26—−3.0% | −44−601%−5.9% | 8.8−77.7%1.2% | 40−46.3%7.5% | 74+56.0%25.7% | 47+79.6%20.6% | 26—14.8% | |
| Earnings per share, basic | 2.50+125%— | 1.11+70.8%— | 0.65—— | -0.31—— | -0.53−542%— | 0.12−79.7%— | 0.59−50.8%— | 1.20+51.9%— | 0.79+75.6%— | 0.45—— | |
| Earnings per share, diluted | 2.46+126%— | 1.09+70.3%— | 0.64—— | -0.31—— | -0.53−542%— | 0.12−79.3%— | 0.58−50.4%— | 1.17+51.9%— | 0.77+75.0%— | 0.44—— | |
| Shares, weighted average (basic) | 86−0.8%— | 87+1.5%— | 86+1.3%— | 84+1.6%— | 83+12.0%— | 74+10.8%— | 67+8.4%— | 62+2.5%— | 60+2.9%— | 59—— | |
| Shares, weighted average (diluted) | 87−1.5%— | 89+2.2%— | 87+3.0%— | 84+1.6%— | 83+9.8%— | 76+10.6%— | 68+8.0%— | 63+2.5%— | 62+3.3%— | 60—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 319+7.8%9.4% | 296−26.7%8.6% | 404+58.9%12.8% | 254+12.8%8.2% | 225−31.4%7.3% | 329+71.5%12.1% | 192−47.0%7.5% | 361+81.2%70.9% | 199+42.5%54.0% | 140—50.1% | |
| Receivables | 124+4.8%3.7% | 118+12.5%3.4% | 105+8.3%3.3% | 97+10.8%3.1% | 87+20.1%2.8% | 73+2.7%2.7% | 71+176%2.8% | 26+18.8%5.0% | 22+27.1%5.9% | 17—6.1% | |
| Inventory | — | — | — | — | — | — | — | — | 0.2−63.7%0.1% | 0.6—0.2% | |
| Other current assets | 70+9.2%2.1% | 64+31.4%1.8% | 49+52.8%1.5% | 32−17.4%1.0% | 38−34.3%1.2% | 59+68.8%2.2% | 35+361%1.4% | 7.5+114%1.5% | 3.5r3.3+23.0%1.0% | 2.9—1.0% | |
| Current assets | 512+7.2%15.2% | 478−14.3%13.9% | 557+45.6%17.6% | 383+9.0%12.4% | 351−23.7%11.3% | 460+54.8%17.0% | 297−24.7%11.6% | 395+48.7%77.4% | 265+32.2%71.9% | 201—71.9% | |
| Property, plant and equipment | 3.2−1.9%0.1% | 3.2−46.1%0.1% | 6.0−53.2%0.2% | 13−45.0%0.4% | 23−19.7%0.8% | 29−13.1%1.1% | 33+307%1.3% | 8.2+4.9%1.6% | 7.8+51.6%2.1% | 5.2—1.9% | |
| Right-of-use (leased) assets | 36−15.9%1.1% | 43−10.7%1.3% | 48−14.3%1.5% | 56−11.2%1.8% | 64−28.9%2.0% | 90+7.6%3.3% | 83—3.2% | — | — | — | |
| Goodwill | 1,6480.0%48.8% | 1,6480.0%47.8% | 1,6480.0%52.1% | 1,648+0.1%53.4% | 1,646+24.0%53.0% | 1,327−0.4%49.0% | 1,333+28553%52.0% | 4.70.0%0.9% | 4.70.0%1.3% | 4.7—1.7% | |
| Other intangible assets | 1,097−8.9%32.5% | 1,205+44.1%34.9% | 836−10.7%26.4% | 936−3.8%30.3% | 973+26.9%31.3% | 767−2.1%28.3% | 783+883%30.5% | 80−4.7%15.6% | 84+28.6%22.7% | 65—23.3% | |
| Investments in associates | — | — | — | — | — | — | — | 0.2—0.0% | — | — | |
| Long-term investments | — | — | — | — | — | — | — | 0.7—0.1% | — | — | |
| Total assets | 3,380−2.0%100% | 3,449+9.0%100% | 3,164+2.4%100% | 3,089−0.6%100% | 3,107+14.6%100% | 2,710+5.7%100% | 2,565+403%100% | 510+38.2%100% | 369+32.3%100% | 279—100% | |
| Accounts payable | 12−15.3%0.4% | 14+19.3%0.4% | 12−13.4%0.4% | 14−49.5%0.4% | 28+1606%0.9% | 1.6−59.4%0.1% | 4.0+13.1%0.2% | 3.5+45.5%0.7% | 2.4−24.9%0.7% | 3.2—1.2% | |
| Debt due within a year | 0—0.0% | 0—0.0% | 0−100%0.0% | 18+100%0.6% | 8.8−86.0%0.3% | 63+60.0%2.3% | 39—1.5% | 0—0.0% | — | — | |
| Current liabilities | 157+0.3%4.6% | 156+33.5%4.5% | 117−10.7%3.7% | 131−14.4%4.2% | 153−25.2%4.9% | 205+34.7%7.6% | 152+423%5.9% | 29+41.8%5.7% | 20+30.5%5.6% | 16—5.6% | |
| Long-term debt | 957−9.4%28.3% | 1,056+20.7%30.6% | 875−3.6%27.7% | 908−1.5%29.4% | 922−0.2%29.7% | 924−21.8%34.1% | 1,182—46.1% | 0—0.0% | — | — | |
| Lease liabilities (non-current) | 34−19.0%1.0% | 42−13.4%1.2% | 49−17.3%1.5% | 59−9.6%1.9% | 65−12.1%2.1% | 74+9.1%2.7% | 68—2.7% | — | — | — | |
| Non-current liabilities | 1,116−5.2%33.0% | 1,177+16.4%34.1% | 1,012−4.8%32.0% | 1,062−3.6%34.4% | 1,101−2.3%35.4% | 1,127−18.5%41.6% | 1,383+35501%53.9% | 3.9+62.2%0.8% | 2.4+60.4%0.6% | 1.5—0.5% | |
| Total liabilities | 1,273−4.5%37.7% | 1,334+18.1%38.7% | 1,129−5.4%35.7% | 1,193−4.9%38.6% | 1,255−5.8%40.4% | 1,332−13.2%49.1% | 1,535+4559%59.8% | 33+43.9%6.5% | 23+33.1%6.2% | 17—6.2% | |
| Retained earnings | 196−6.4%5.8% | 209+1.8%6.1% | 206+37.2%6.5% | 150−14.8%4.9% | 176−20.1%5.7% | 220+4.2%8.1% | 212+23.1%8.2% | 172+101%33.7% | 85+184%23.1% | 30—10.7% | |
| Shareholders' equity | 2,107−0.4%62.3% | 2,115+3.9%61.3% | 2,035+7.4%64.3% | 1,896+2.3%61.4% | 1,853+34.4%59.6% | 1,379+33.8%50.9% | 1,030+116%40.2% | 477+37.8%93.5% | 346+32.2%93.8% | 262—93.8% | |
| Total liabilities and equity | 3,380−2.0%100% | 3,449+9.0%100% | 3,164+2.4%100% | 3,089−0.6%100% | 3,107+14.6%100% | 2,710+5.7%100% | 2,565+403%100% | 510+38.2%100% | 369+32.3%100% | 279—100% | |
| Shares outstanding | 85−1.8%— | 87+0.5%— | 86+1.6%— | 85+1.2%— | 84+8.6%— | 77+8.6%— | 71+13.8%— | 62+2.7%— | 61+2.2%— | 60—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 155−4.8%11.8% | 162+6.1%13.5% | 153−5.0%15.3% | 161+17.5%18.7% | 137+18.4%18.1% | 116+109%15.8% | 55+204%10.4% | 18+14.0%6.3% | 16+21.0%7.0% | 13—7.4% | |
| Share-based compensation | 73−24.2%5.6% | 96+25.0%8.0% | 77+23.2%7.7% | 63+18.7%7.3% | 53+23.1%7.0% | 43+7.6%5.8% | 40+89.2%7.5% | 21+47.1%7.3% | 14+70.4%6.2% | 8.4—4.7% | |
| Cash from operating activities | 457+34.5%34.8% | 340+40.0%28.3% | 243+61.2%24.3% | 151+6.8%17.5% | 141−22.4%18.6% | 182+73.0%24.8% | 105−7.4%19.7% | 113+38.8%39.5% | 82+79.2%35.6% | 46—25.6% | |
| Capital expenditure | −2.0—−0.1% | −2.1—−0.2% | −1.7—−0.2% | −3.4—−0.4% | −8.9—−1.2% | −13—−1.8% | −7.3—−1.4% | −3.9—−1.3% | −5.5—−2.4% | −3.6—−2.0% | |
| Intangible assets bought | −0.3—−0.0% | −452—−37.7% | −3.3—−0.3% | −71—−8.2% | −65—−8.7% | −32—−4.4% | −9.1—−1.7% | −1.2—−0.4% | −18—−7.6% | 0—0.0% | |
| Acquisitions, net of cash acquired | — | — | 0—0.0% | 0—0.0% | −505—−66.7% | 0—0.0% | −1,645—−309% | 0—0.0% | −2.9—−1.3% | — | |
| Cash from investing activities | −47—−3.6% | −505—−42.1% | −46—−4.6% | −119—−13.8% | −639—−84.5% | −97—−13.2% | −1,740−6885%−327% | 26—8.9% | −37—−16.0% | −13—−7.3% | |
| Debt issued | 0−100%0.0% | 737—61.4% | 0—0.0% | 0−100%0.0% | 950—126% | 0−100%0.0% | 1,250—235% | 0—0.0% | 0—0.0% | — | |
| Debt repaid | −100—−7.6% | −562—−46.8% | −54—−5.4% | −8.8—−1.0% | −1,003—−133% | −239—−32.6% | −7.8—−1.5% | 0—0.0% | 0—0.0% | — | |
| Shares issued | — | — | 0—0.0% | 0−100%0.0% | 457+59.2%60.4% | 287−37.5%39.1% | 458—86.2% | 0—0.0% | 0—0.0% | — | |
| Shares bought back | −299—−22.8% | −121—−10.1% | 0—0.0% | 0—0.0% | — | — | — | — | — | — | |
| Dividends paid | — | — | — | — | — | — | — | — | — | 0—0.0% | |
| Cash from financing activities | −387−772%−29.5% | 58—4.8% | −47—−4.7% | −2.7−101%−0.3% | 395+653%52.2% | 52−96.4%7.1% | 1,466+6292%276% | 23+57.4%8.0% | 15−38.7%6.3% | 24—13.3% | |
| Change in cash | 23—1.7% | −108−172%−9.0% | 150+419%15.0% | 29—3.3% | −103−175%−13.7% | 137—18.7% | −170−205%−31.9% | 162+172%56.4% | 60+5.7%25.9% | 56—31.6% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Jul 31, 2026 | Q2 FY2026to Jul 31, 2026 | Q1 FY2026to Apr 30, 2026 | Q4 FY2025to Jan 31, 2026 | Q3 FY2025to Oct 31, 2025 | Q2 FY2025to Jul 31, 2025 | Q1 FY2025to Apr 30, 2025 | Q4 FY2024to Jan 31, 2025 | Q3 FY2024to Oct 31, 2024 | Q2 FY2024to Jul 31, 2024 | Q1 FY2024to Apr 30, 2024 | Q4 FY2023to Jan 31, 2024 | Q3 FY2023to Oct 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 1,362+7.3%100% | 351+7.6%100% | 355+7.2%100% | 335*+7.3%100% | 322+7.2%100% | 326+8.6%100% | 331+15.0%100% | 312*+18.8%100% | 300+20.5%100% | 300—100% | 288—100% | 262—100% | 249—100% | |
| Cost of revenue | 392−8.1%28.8% | 93−0.5%26.5% | 98−7.7%27.7% | 106*−13.3%31.8% | 94−9.0%29.2% | 93−2.7%28.6% | 107+6.0%32.2% | 123*+23.9%39.4% | 103+14.8%34.4% | 96—32.0% | 100—34.9% | 99—37.8% | 90r91—36.1% | |
| Gross profit | 970+15.1%71.2% | 258+10.9%73.5% | 256+14.3%72.3% | 228*+20.7%68.2% | 228+15.8%70.8% | 233+14.0%71.4% | 224+19.9%67.8% | 189*+15.8%60.6% | 197+23.8%65.6% | 204—68.0% | 187—65.1% | 163—62.2% | 159r158—63.9% | |
| Research and development | 278+10.7%20.4% | 74+14.1%21.1% | 68+10.3%19.1% | 70*+8.8%21.0% | 66+9.5%20.5% | 65+10.6%19.9% | 61+9.5%18.6% | 65*+17.0%20.7% | 60+8.2%20.0% | 59—19.5% | 56—19.5% | 55*—21.1% | 56—22.3% | |
| Selling and marketing | 99+8.5%7.3% | 23+16.5%6.6% | 27+3.3%7.6% | 25*+8.0%7.4% | 24+7.8%7.6% | 20−7.4%6.1% | 26+10.6%7.9% | 23*+12.3%7.4% | 23+15.2%7.5% | 22—7.2% | 23—8.2% | 21*—7.8% | 20—7.9% | |
| General and administrative | 130+11.2%9.6% | 35+16.3%9.9% | 31+21.9%8.8% | 34*+11.8%10.0% | 31−2.9%9.6% | 30−7.0%9.2% | 26−33.2%7.7% | 30*+29.5%9.6% | 32+17.1%10.6% | 32—10.8% | 38—13.3% | 23r25*—8.8% | 27r26—10.9% | |
| Operating expenses | 619+1.7%45.4% | 159+11.4%45.4% | 153+8.6%43.2% | 157*+6.9%46.9% | 149−15.8%46.4% | 143−1.5%43.9% | 141−2.9%42.7% | 147*+18.0%47.1% | 177+38.3%59.0% | 145—48.4% | 146—50.6% | 124—47.4% | 128r128—51.5% | |
| Operating income | 351+49.9%25.8% | 99+10.1%28.1% | 103+23.9%29.0% | 71*+68.6%21.2% | 79+301%24.4% | 90+52.1%27.5% | 83+99.6%25.1% | 42*+8.4%13.5% | 20−36.5%6.5% | 59—19.6% | 42—14.5% | 39*—14.8% | 31—12.4% | |
| Interest expense and finance costs | 53−16.9%3.9% | 13−15.7%3.6% | 13−15.3%3.5% | 13*−13.0%4.0% | 14−22.6%4.4% | 15−3.1%4.6% | 15+26.0%4.5% | 15*+11.8%4.9% | 18+34.0%6.0% | 15—5.1% | 12—4.1% | 14*—5.2% | 14—5.4% | |
| Other non-operating income (expense) | −43—−3.1% | −11—−3.1% | −11—−3.0% | −10*—−3.0% | −11—−3.5% | −12—−3.5% | −12—−3.7% | −12*—−3.9% | −13—−4.5% | −12—−4.1% | −8.4—−2.9% | −9.2—−3.5% | −9.8—−3.9% | |
| Income before tax | 309+66.7%22.7% | 88+12.6%25.1% | 92+30.2%26.1% | 61*+103%18.2% | 68+986%21.0% | 78+67.4%24.0% | 71+113%21.4% | 30*+0.8%9.6% | 6.2−70.5%2.1% | 47—15.5% | 33—11.6% | 30*—11.3% | 21—8.5% | |
| Income tax | 72+83.6%5.3% | 22+22.1%6.3% | 23+35.0%6.5% | 11*+210%3.3% | 16+2976%4.9% | 18+68.6%5.6% | 17+285%5.1% | 3.6*+7.2%1.2% | 0.5−92.0%0.2% | 11—3.6% | 4.4—1.5% | 3.4—1.3% | 6.4—2.6% | |
| Net income attributable to shareholders | 236+62.2%17.4% | 66+9.7%18.7% | 69+28.8%19.6% | 50*+88.7%14.9% | 52+806%16.0% | 60+67.1%18.4% | 54+87.1%16.3% | 26*+0.0%8.5% | 5.7−61.1%1.9% | 36—11.9% | 29—10.0% | 26—10.0% | 15—5.9% | |
| Earnings per share, basic | — | 0.79+14.5%— | 0.82+32.3%— | — | 0.60+757%— | 0.69+68.3%— | 0.62+87.9%— | — | 0.07−58.8%— | 0.41—— | 0.33—— | — | 0.17—— | |
| Earnings per share, diluted | — | 0.78+14.7%— | 0.82+34.4%— | — | 0.59+883%— | 0.68+70.0%— | 0.61+84.8%— | — | 0.06−64.7%— | 0.40—— | 0.33—— | — | 0.17—— | |
| Shares, weighted average (basic) | 83−3.7%— | 83−3.7%— | 84−2.6%— | — | 86−1.4%— | 87−0.7%— | 87+0.2%— | — | 87+1.7%— | 87—— | 86—— | — | 86—— | |
| Shares, weighted average (diluted) | 84−4.3%— | 84−4.3%— | 85−3.9%— | — | 87−1.9%— | 88−1.0%— | 88+0.1%— | — | 89+1.7%— | 89—— | 88—— | — | 87—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 256—7.8% | 256−15.9%7.8% | 265−7.8%8.0% | 319+7.8%9.4% | 309−4.0%9.1% | 304−6.9%8.9% | 288+14.6%8.4% | 296−26.7%8.6% | 322−3.6%9.2% | 327—9.3% | 251—7.7% | 404—12.8% | 334—10.8% | |
| Receivables | 122—3.7% | 122+9.9%3.7% | 122+4.9%3.7% | 124+4.8%3.7% | 111+4.2%3.3% | 111+2.5%3.3% | 116+9.5%3.4% | 118+12.5%3.4% | 107+10.9%3.1% | 108—3.1% | 106—3.3% | 105—3.3% | 96—3.1% | |
| Other current assets | 82—2.5% | 82+6.2%2.5% | 79+15.3%2.4% | 70+9.2%2.1% | 78+17.8%2.3% | 77+28.1%2.3% | 69+44.7%2.0% | 64+31.4%1.8% | 66+50.3%1.9% | 60—1.7% | 47—1.5% | 49—1.5% | 44—1.4% | |
| Current assets | 460—14.1% | 460−6.6%14.1% | 467−1.3%14.1% | 512+7.2%15.2% | 499+0.7%14.7% | 493−0.6%14.4% | 473+16.8%13.8% | 478−14.3%13.9% | 495+4.4%14.2% | 496—14.1% | 405—12.5% | 557—17.6% | 474—15.3% | |
| Property, plant and equipment | 4.8—0.1% | 4.8+56.2%0.1% | 3.8+19.8%0.1% | 3.2−1.9%0.1% | 3.4−12.9%0.1% | 3.1−32.8%0.1% | 3.2−37.6%0.1% | 3.2−46.1%0.1% | 3.9−49.2%0.1% | 4.6—0.1% | 5.1—0.2% | 6.0—0.2% | 7.7—0.2% | |
| Right-of-use (leased) assets | 33—1.0% | 33−17.3%1.0% | 35−16.6%1.0% | 36−15.9%1.1% | 38−15.2%1.1% | 40−14.5%1.2% | 41−13.8%1.2% | 43−10.7%1.3% | 45−10.9%1.3% | 46—1.3% | 48—1.5% | 48—1.5% | 50—1.6% | |
| Goodwill | 1,648—50.4% | 1,6480.0%50.4% | 1,6480.0%49.9% | 1,6480.0%48.8% | 1,6480.0%48.5% | 1,6480.0%48.2% | 1,6480.0%48.2% | 1,6480.0%47.8% | 1,6480.0%47.2% | 1,648—46.9% | 1,648—50.8% | 1,648—52.1% | 1,648—53.3% | |
| Other intangible assets | 1,048—32.0% | 1,048−9.1%32.0% | 1,073−9.0%32.5% | 1,097−8.9%32.5% | 1,125−8.4%33.1% | 1,152−8.1%33.7% | 1,179+10.1%34.5% | 1,205+44.1%34.9% | 1,228+42.8%35.2% | 1,254—35.7% | 1,071—33.0% | 836—26.4% | 861—27.8% | |
| Total assets | 3,271—100% | 3,271−4.3%100% | 3,306−3.2%100% | 3,380−2.0%100% | 3,398−2.6%100% | 3,417−2.8%100% | 3,416+5.2%100% | 3,449+9.0%100% | 3,488+12.8%100% | 3,514—100% | 3,246—100% | 3,164—100% | 3,094—100% | |
| Accounts payable | 8.6—0.3% | 8.6−10.5%0.3% | 14+5.4%0.4% | 12−15.3%0.4% | 20+88.8%0.6% | 9.6−9.1%0.3% | 13−25.7%0.4% | 14+19.3%0.4% | 10−22.9%0.3% | 11—0.3% | 18—0.6% | 12—0.4% | 13—0.4% | |
| Debt due within a year | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Current liabilities | 154—4.7% | 154+31.9%4.7% | 136+16.7%4.1% | 157+0.3%4.6% | 121−21.9%3.5% | 117−3.6%3.4% | 116+26.2%3.4% | 156+33.5%4.5% | 155+60.6%4.4% | 121—3.4% | 92—2.8% | 117—3.7% | 96—3.1% | |
| Long-term debt | 931—28.5% | 931−7.5%28.5% | 943−10.8%28.5% | 957−9.4%28.3% | 982−9.2%28.9% | 1,007−8.6%29.5% | 1,057+14.1%30.9% | 1,056+20.7%30.6% | 1,081+23.7%31.0% | 1,101—31.3% | 926—28.5% | 875—27.7% | 874—28.3% | |
| Lease liabilities (non-current) | 30—0.9% | 30−21.6%0.9% | 32−20.2%1.0% | 34−19.0%1.0% | 36−18.0%1.1% | 38−17.2%1.1% | 40−16.6%1.2% | 42−13.4%1.2% | 44−12.6%1.3% | 46—1.3% | 48—1.5% | 49—1.5% | 51—1.6% | |
| Non-current liabilities | 1,127—34.5% | 1,127−2.3%34.5% | 1,123−4.5%34.0% | 1,116−5.2%33.0% | 1,143−5.4%33.6% | 1,154−6.7%33.8% | 1,176+11.3%34.4% | 1,177+16.4%34.1% | 1,209+19.8%34.7% | 1,237—35.2% | 1,056—32.5% | 1,012—32.0% | 1,009—32.6% | |
| Total liabilities | 1,281—39.2% | 1,281+0.9%39.2% | 1,259−2.6%38.1% | 1,273−4.5%37.7% | 1,264−7.3%37.2% | 1,270−6.4%37.2% | 1,292+12.5%37.8% | 1,334+18.1%38.7% | 1,364+23.3%39.1% | 1,357—38.6% | 1,149—35.4% | 1,129—35.7% | 1,106—35.7% | |
| Retained earnings | 163—5.0% | 163−28.3%5.0% | 177−18.8%5.4% | 196−6.4%5.8% | 208−10.2%6.1% | 227−16.0%6.6% | 218−6.9%6.4% | 209+1.8%6.1% | 232+29.2%6.6% | 270—7.7% | 234—7.2% | 206—6.5% | 179—5.8% | |
| Shareholders' equity | 1,990—60.8% | 1,990−7.3%60.8% | 2,047−3.6%61.9% | 2,107−0.4%62.3% | 2,134+0.4%62.8% | 2,146−0.5%62.8% | 2,124+1.2%62.2% | 2,115+3.9%61.3% | 2,125+6.9%60.9% | 2,157—61.4% | 2,098—64.6% | 2,035—64.3% | 1,988—64.3% | |
| Total liabilities and equity | 3,271—100% | 3,271−4.3%100% | 3,306−3.2%100% | 3,380−2.0%100% | 3,398−2.6%100% | 3,417−2.8%100% | 3,416+5.2%100% | 3,449+9.0%100% | 3,488+12.8%100% | 3,514—100% | 3,246—100% | 3,164—100% | 3,094—100% | |
| Shares outstanding | 83—— | 83−4.1%— | 84−3.2%— | 85−1.8%— | 86−1.4%— | 86−1.0%— | 87−0.3%— | 87+0.5%— | 87+1.2%— | 87—— | 87—— | 86—— | 86—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 158+0.3%11.6% | 42*+9.1%12.0% | 38−1.4%10.8% | 39*−1.3%11.6% | 39*−4.8%12.0% | 38*−11.8%11.8% | 39−0.5%11.7% | 39*+3.4%12.6% | 41*+7.8%13.6% | 44*—14.5% | 39—13.5% | 38*—14.4% | 38*—15.2% | |
| Share-based compensation | 81+6.6%6.0% | 22+16.5%6.3% | 19+35.4%5.5% | 19*−11.9%5.7% | 21−2.8%6.4% | 19−11.6%5.9% | 14−55.2%4.3% | 22*+26.1%7.0% | 21−2.5%7.0% | 22—7.2% | 32—11.1% | 17*—6.6% | 22—8.7% | |
| Cash from operating activities | 490+33.6%36.0% | 136*+0.2%38.8% | 98+50.6%27.5% | 118*+55.7%35.2% | 139*+53.0%43.0% | 136*+25.7%41.7% | 65−1.1%19.6% | 76*−1.7%24.3% | 91*+58.6%30.1% | 108*—36.1% | 65—22.8% | 77*—29.4% | 57*—22.9% | |
| Capital expenditure | −2.5—−0.2% | −1.0*—−0.3% | −0.4—−0.1% | −0.3*—−0.1% | −0.8*—−0.2% | −0.8*—−0.2% | −0.1—−0.0% | −0.3*—−0.1% | −0.3*—−0.1% | −0.7*—−0.2% | −0.7—−0.3% | −0.6*—−0.2% | −0.5*—−0.2% | |
| Intangible assets bought | — | — | — | 0*—0.0% | −0.3*—−0.1% | 0*—0.0% | 0—0.0% | 0*—0.0% | 0*—0.0% | −196*—−65.4% | −256—−89.1% | 0*—0.0% | −3.3*—−1.3% | |
| Cash from investing activities | −60—−4.4% | −26*—−7.4% | −14—−3.9% | −8.4*—−2.5% | −11*—−3.5% | −11*—−3.4% | −16—−4.9% | −14*—−4.3% | −13*—−4.3% | −209*—−69.7% | −270—−93.9% | −11*—−4.3% | −15*—−6.2% | |
| Debt issued | — | — | — | 0*—0.0% | 0*−100%0.0% | 0*−100%0.0% | 0−100%0.0% | 0*—0.0% | 512*—170% | 175*—58.3% | 50—17.4% | 0*—0.0% | 0*—0.0% | |
| Debt repaid | −77—−5.6% | −12*—−3.4% | −15—−4.2% | −25*—−7.5% | −25*—−7.8% | −50*—−15.3% | 0—0.0% | −25*—−8.0% | −537*—−179% | 0*—0.0% | 0—0.0% | 0*—0.0% | 0*—0.0% | |
| Shares bought back | −404—−29.7% | −108*—−30.7% | −123—−34.8% | −81*—−24.2% | −92*—−28.7% | −67*—−20.5% | −59—−17.9% | −63*—−20.2% | −59*—−19.5% | 0*—0.0% | 0—0.0% | 0*—0.0% | — | |
| Cash from financing activities | −479—−35.2% | −120*—−34.1% | −137—−38.7% | −100*—−29.8% | −122*—−38.0% | −108*−161%−33.2% | −57−209%−17.1% | −88*−2248%−28.4% | −82*−4164%−27.4% | 177*—58.9% | 52—18.0% | 4.1*—1.6% | 2.0*—0.8% | |
| Change in cash | −48—−3.6% | −9.4*−157%−2.7% | −54—−15.1% | 9.7*—2.9% | 4.8*—1.5% | 17*−78.1%5.1% | −8.1—−2.4% | −26*−137%−8.4% | −4.7*−111%−1.6% | 76*—25.2% | −153—−53.1% | 70*—26.6% | 44*—17.5% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Jul 31, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What HealthEquity, Inc. sells: revenue by product line, fiscal 2026#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Custodial$637 M48%+17%
- Service(total)$485 M37%+1.4%
- Interchange$192 M15%+8.8%
Source: SEC annual report (XBRL data) · as of Jan 31, 2026
Where HealthEquity, Inc. operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for HealthEquity, Inc.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇺🇸 USA | Headquarters2 offices | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at HealthEquity, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2026Scott Cutler | $13.6 M | $10.4 M | $4.4 M | $103 (peers $81) |
| 2025Jon Kessler, Scott Cutler | $12.6 M | $36.8 M | $5.0 M | $132 (peers $102) |
| 2024Jon Kessler | $13.4 M | $22.9 M | $3.9 M | $90 (peers $76) |
| 2023Jon Kessler | $13.4 M | $14.4 M | $5.6 M | $73 (peers $73) |
| 2022Jon Kessler | $9.9 M | −$5.5 M | $2.4 M | $64 (peers $93) |
Source: SEC proxy statement (Form DEF 14A) · as of Jan 31, 2026
Events at HealthEquity, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 8 · Material agreement 2 · Agreement ended 1 · New debt 1 · Shareholder vote 3 · Results announced 12
| Filed | What happened | Filing |
|---|---|---|
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Material agreementAgreement endedNew debt | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Oct 9, 2026
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2011 | $13 M | Issued in a merger or acquisition | $10 to $50 million | 2 | equity, debt, options | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
Government contracts: HealthEquity, Inc.#
$26.9 M in federal contracts in fiscal 2026, mostly from Office of Personnel Management and Department of Veterans Affairs.
- Office of Personnel Management$23.0 M
- Department of Veterans Affairs$2.7 M
- Department of Defense$550 K
- Department of Homeland Security$188 K
- Consumer Financial Protection Bureau$61 K
- Department of Health and Human Services$60 K
| Fiscal year | Contracts | Grants |
|---|---|---|
| FY2027 (to date) | $350 | — |
| FY2026 | $26.9 M | — |
| FY2025 | $21.0 M | — |
| FY2024 | $18.5 M | — |
| FY2023 | $15.9 M | — |
| FY2022 | $9.9 M | — |
| FY2021 | $9.7 M | — |
| FY2020 | $422 K | — |
Source: USAspending.gov. Obligations are binding promises to pay, not payments, and can be negative when an award is cut. Counted under HealthEquity, Inc.: HEALTHEQUITY, INC. (UEI JHYDEGZ72RH3)
Lobbying by HealthEquity, Inc.#
$3.2 M spent on lobbying the US Congress and federal agencies in 2025, most often on health issues and taxation/internal revenue code.
- Health Issues18 reports
- Taxation/Internal Revenue Code12 reports
Lobbying firms hired in 2025
BOCKORNY GROUP, INC. $185 K · Tarplin, Downs & Young, LLC $160 K · Groom Law Group, Chartered $80 K · ACTUM I, LLC $60 K · Federal Policy Group, LLC $60 K
The firms' fees are part of HealthEquity, Inc.'s own reported expenses, so they are not added again.
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $1.8 M | $1.8 M | 12 |
| 2025 | $3.2 M | $3.2 M | 19 |
| 2024 | $2.8 M | $2.8 M | 20 |
| 2023 | $1.7 M | $1.7 M | 14 |
| 2022 | $770 K | $700 K | 8 |
| 2021 | $220 K | — | 7 |
| 2020 | $250 K | — | 6 |
| 2019 | $280 K | — | 5 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “HealthEquity fka as Wage Works”, “HealthEquity” and “HealthEquity, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
H-1B hiring at HealthEquity, Inc.#
14 labor condition applications certified in fiscal 2026 for 14 positions, at a median wage of $157 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Senior Software EngineerSoftware Developers | 4 | $160 K |
| Sr. Applications DeveloperSoftware Developers | 2 | $136 K |
| Sr. Software EngineerSoftware Developers | 2 | $162 K |
| Application Integration SpecialistSoftware Developers | 1 | $140 K |
| CRM Data AnalystBusiness Intelligence Analysts | 1 | $95 K |
| Director of Software EngineeringComputer and Information Systems Managers | 1 | $215 K |
| Senior Platform EngineerSoftware Developers | 1 | $159 K |
| Senior Site Reliability EngineerSoftware Developers | 1 | $141 K |
| Sr. Site Reliability EngineerSoftware Developers | 1 | $133 K |
Where: Zephyrhills, FL 2 · Fremont, CA 2 · Chesterfield, MO 1 · Gilroy, CA 1 · Plainsboro, NJ 1 · Tampa, FL 1 · Leander, TX 1 · Wesley Chapel, FL 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 14 | 14 | $157 K | 15 |
| FY2025 | 15 | 15 | $155 K | 15 |
| FY2024 | 8 | 8 | $139 K | 8 |
| FY2023 | 31 | 31 | $145 K | 31 |
| FY2022 | 3 | 3 | $78 K | 3 |
| FY2021 | 2 | 2 | $96 K | 2 |
| FY2020 | 2 | 2 | $61 K | 2 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as HealthEquity, Inc.
Discuss HealthEquity, Inc.#
2 automatic updates and 0 member comments. Sign in to comment and react.
- Insider trading in October 2026automatic update · Oct 31, 2026
Directors and officers of HealthEquity, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider bought shares worth about $9,756 in 1 trade. Awards, option exercises and shares withheld for tax are not counted.
- Mutual funds: 435 funds hold $4.0 billionautomatic update · Jul 31, 2026
435 mutual funds in 2 countries hold shares of HealthEquity, Inc. worth $4.0 billion, about 53.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 214 funds added shares and 162 sold; on balance they bought $112 million. Share splits are not counted as trading.
How HealthEquity, Inc. compares in Healthcare Information Services
- Market cap$8.3 B · higher than 92% of 37
- Revenue$1.3 B · higher than 84% of 70
- Net margin17.4% · higher than 90% of 68
- Revenue growth9.5% · higher than 54% of 38
- P/E ratio35.3× · lower than 81% of 17
- Price / sales6.1× · lower than 33% of 28
- Price / book4.0× · lower than 30% of 28
- FCF yield5.5% · higher than 60% of 21
- 🇺🇸 10x Genomics, Inc.$9.4 B
- 🇯🇵 M3, Inc.$7.1 B
- 🇺🇸 Doximity, Inc.$5.5 B
- 🇦🇺 Pro Medicus Limited$14.4 B
- 🇺🇸 Privia Health Group, Inc.$2.8 B
- 🇨🇳 Winning Health Technology Group Co., Ltd.$2.3 B
Peer comparison · Healthcare Information Services
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| HealthEquity, Inc.🇺🇸 | $8.3 B | 35.3× | 17.4% | +9.5% |
| Veeva Systems Inc.🇺🇸 | $50.2 B | 49.5× | 29.4% | +16.3% |
| Pro Medicus Limited🇦🇺 | $14.4 B | 81.3× | — | — |
| 10x Genomics, Inc.🇺🇸 | $9.4 B | — | -10.8% | +5.3% |
| M3, Inc.🇯🇵 | $7.1 B | 21.5× | 14.0% | — |
| Doximity, Inc.🇺🇸 | $5.5 B | 39.5× | 21.1% | +13.1% |
| Privia Health Group, Inc.🇺🇸 | $2.8 B | 80.9× | 1.4% | +22.3% |
| Winning Health Technology Group Co., Ltd.🇨🇳 | $2.3 B | 41.3× | 13.8% | — |
| Progyny, Inc.🇺🇸 | $2.1 B | 23.1× | 6.8% | +10.4% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- 10x Genomics, Inc.$9.4 B
- M3, Inc.$7.1 B
- Doximity, Inc.$5.5 B
- Pro Medicus Limited$14.4 B
- Privia Health Group, Inc.$2.8 B
- Winning Health Technology Group Co., Ltd.$2.3 B
Sources and freshness
- Market cap:
- Oct 28, 2026
- Annual results:
- For year ending January-2026
- Balance sheet:
- As of January-2026
- Employees:
- As of January 31, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, Wikipedia, Wikidata, GLEIF register; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at HealthEquity, Inc.? Verify and update this profile — free
Show HealthEquity, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.